| Literature DB >> 29674673 |
Minghui Shen1,2, Guilan Di3,4, Min Li1, Jingqiang Fu1, Qi Dai1, Xiulian Miao5, Miaoqin Huang1, Weiwei You1, Caihuan Ke6.
Abstract
The ivory shell, Babylonia areolata, is a commercially important aquaculture species in the southeast coast of mainland China. The middle veliger stage, later veliger stage, and juvenile stage are distinct larval stages in B. areolata development. In this study, we used label-free quantification proteomics analysis of the three developmental stages of B. areolata. We identified a total of 5,583 proteins, of which 1,419 proteins expression level showed significant differential expression. The results of gene ontology enrichment analysis showed that the number of proteins involved in metabolic and cellular processes were the most abundant. Those proteins mostly had functions such as binding, catalytic activity and transporter activity. The results of Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that the number of proteins involved in the ribosome, carbon metabolism, and lysosome pathways were the most abundant, indicating that protein synthesis and the immune response were active during the three stages of development. This is the first study to use proteomics and real-time PCR to study the early developmental stages of B. areolata, which could provide relevant data on gastropod development. Our results provide insights into the novel aspects of protein function in shell formation, body torsion, changes in feeding habits, attachment and metamorphosis, immune-related activities in B. areolata larvae.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29674673 PMCID: PMC5908917 DOI: 10.1038/s41598-018-24645-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Embryonic development of Babylonia areolata. (a) Veliger before attachment (b) Veliger at the later metamorphosis stage (velum atrophy) (c) Juvenile B. areolata, the feeding habits change from phytophagy to sarcophagy.
Protein and peptide fragment concentration determination.
| Sample ID | Concentration (μg/μL) | Volume (μL) | Total Quantity (μg) | Type Evaluation | Peptide Concentration (μg/μL) |
|---|---|---|---|---|---|
| ZRZ_III-1 | 26.83 | 200 | 5,400 | A | 1.84 |
| ZRZ_III-2 | 26.75 | 200 | 5,400 | A | 1.73 |
| ZRZ_III-3 | 26.26 | 200 | 5,400 | A | 1.68 |
| ZRZ_V-1 | 24.11 | 200 | 4,800 | A | 1.59 |
| ZRZ_V-2 | 24.35 | 200 | 4,800 | A | 1.75 |
| ZRZ_V-3 | 24.28 | 200 | 4,800 | A | 1.61 |
| ZRZ_VI-1 | 15.05 | 200 | 3,000 | A | 1.83 |
| ZRZ_VI-2 | 10.20 | 200 | 2,000 | A | 1.01 |
| ZRZ_VI-3 | 4.26 | 200 | 850 | A | 1.63 |
Figure 2SDS-PAGE analysis. Marker show the protein molecular weight standard, ZRZ-III show the middle veliger stage, ZRZ-V represent later veliger stage, and ZRZ-VI represent juvenile snail stage.
Top BLAST hits.
| Sequence Name | Hit Description | Bit Score | Sequences (n) |
|---|---|---|---|
| c268231_g4 | spectrin beta chain-like isoform X3 | 3749.9 | 1986 |
| c268656_g2 | myosin heavy chain, striated muscle-like isoform X11 | 2845.07 | 1599 |
| c268768_g1 | dynein beta chain, ciliary-like | 3054.23 | 1450 |
| c265341_g2 | rootletin-like isoform X6 | 2313.11 | 1390 |
| c267248_g4 | filamin-A-like isoform X4 | 2758.79 | 1383 |
| c260248_g1 | dynein heavy chain 5, axonemal-like | 2678.66 | 1307 |
| c268675_g1 | hypothetical protein LOTGIDRAFT_218488 | 2144.01 | 1165 |
| c267808_g1 | splicing factor 3B subunit 1-like isoform X1 | 2052.33 | 1054 |
| c266291_g1 | spectrin alpha chain-like isoform X7 | 2029.22 | 1025 |
| c268690_g2 | twitchin-like | 2174.05 | 1022 |
| c268077_g2 | uncharacterized protein LOC101849429 | 2081.6 | 1008 |
| c261417_g3 | dynein heavy chain 10, axonemal-like | 1841.63 | 1004 |
| c268754_g1 | uncharacterized protein LOC105329380 isoform X2 | 1453.73 | 993 |
| c268643_g1 | deleted in malignant brain tumors 1 protein-like isoform X2 | 1802.72 | 976 |
| c268439_g1 | hypothetical protein LOTGIDRAFT_218145 | 1899.02 | 968 |
| c267364_g1 | translational activator GCN1 | 1925.98 | 946 |
| c268713_g4 | dynein beta chain, ciliary-like | 1924.83 | 937 |
| c268768_g2 | dynein beta chain, ciliary-like | 1825.83 | 937 |
| c263230_g7 | dynein heavy chain 7, axonemal-like | 1858.57 | 919 |
| c268195_g2 | sodium/potassium-transporting ATPase subunit alpha-like | 1798.1 | 894 |
| c264969_g2 | calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type-like | 1763.04 | 865 |
| c258154_g7 | hypothetical protein LOTGIDRAFT_137237 | 1788.08 | 839 |
| c265761_g2 | uncharacterized protein LOC101848762 | 1650.18 | 835 |
| c268389_g3 | laminin subunit beta-1-like | 1594.71 | 831 |
| c256031_g1 | dynein heavy chain 1, axonemal-like | 1699.49 | 823 |
| c268690_g3 | twitchin-like | 1499.57 | 811 |
| c260032_g1 | twitchin-like | 1611.66 | 808 |
| c267456_g1 | armadillo repeat-containing protein 4-like | 1445.64 | 789 |
| c264438_g1 | spectrin alpha chain-like isoform X7 | 1513.82 | 778 |
| c267460_g1 | ghypothetical protein LOTGIDRAFT_233044 | 1642.48 | 777 |
| c258721_g2 | vigilin-like | 1579.69 | 773 |
The number of differential proteins.
| V/III | VI/III | VI/V | ||||
|---|---|---|---|---|---|---|
| Qualitative difference | Quantitative difference | Qualitative difference | Quantitative difference | Qualitative difference | Quantitative difference | |
| Up-regulation | 214 | 74 | 348 | 281 | 213 | 168 |
| Down-regulation | 90 | 62 | 385 | 259 | 368 | 206 |
| The number of proteins | 304 | 3657 | 733 | 3253 | 581 | 3461 |
Figure 3Cluster analysis of DEPs. Heat map showed the clustered data, each colored cell represents a protein abundance value. Colors ranging from green to red represent protein abundance from the highest level of down-regulation to the highest level of up-regulation, respectively.
Figure 4GO Functional classification.
GO molecular fuction annotation of Top BLAST hits.
| Sequence Name | Hit Description | GO:MF |
|---|---|---|
| c268231_g4 | spectrin beta chain-like isoform X3 | actin binding |
| c268656_g2 | myosin heavy chain, striated muscle-like isoform X11 | ATP binding |
| c268768_g1 | dynein beta chain, ciliary-like | ATP binding |
| c265341_g2 | rootletin-like isoform X6 | centrosome organization |
| c267248_g4 | filamin-A-like isoform X4 | actin filament binding |
| c260248_g1 | dynein heavy chain 5, axonemal-like | calcium ion binding |
| c268675_g1 | hypothetical protein LOTGIDRAFT_218488 | calcium ion binding |
| c267808_g1 | splicing factor 3B subunit 1-like isoform X1 | nucleotide binding |
| c266291_g1 | spectrin alpha chain-like isoform X7 | phospholipid binding |
| c268690_g2 | twitchin-like | nucleotide binding |
| c268077_g2 | uncharacterized protein LOC101849429 | lipid transporter activity |
| c261417_g3 | dynein heavy chain 10, axonemal-like | ATPase activity |
| c268754_g1 | uncharacterized protein LOC105329380 isoform X2 | zinc ion binding |
| c268643_g1 | deleted in malignant brain tumors 1 protein-like isoform X2 | scavenger receptor activi |
| c268439_g1 | hypothetical protein LOTGIDRAFT_218145 | calcium ion binding |
| c267364_g1 | translational activator GCN1 | kinase regulator activity |
| c268713_g4 | dynein beta chain, ciliary-like | ATP binding |
| c268768_g2 | dynein beta chain, ciliary-like | ATP binding |
| c263230_g7 | dynein heavy chain 7, axonemal-like | ATPase activity |
| c268195_g2 | sodium/potassium-transporting ATPase subunit alpha-like | metal ion binding |
| c264969_g2 | calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type-like | calcium-transporting ATPase activity |
| c258154_g7 | hypothetical protein LOTGIDRAFT_137237 | calcium ion binding |
| c265761_g2 | uncharacterized protein LOC101848762 | hydrolase activity |
| c268389_g3 | laminin subunit beta-1-like | protein binding |
| c256031_g1 | dynein heavy chain 1, axonemal-like | microtubule-based movement |
| c268690_g3 | twitchin-like | nucleotide binding |
| c260032_g1 | twitchin-like | protein kinase activity |
| c267456_g1 | armadillo repeat-containing protein 4-like | protein binding |
| c264438_g1 | spectrin alpha chain-like isoform X7 | calcium ion binding |
| c267460_g1 | hypothetical protein LOTGIDRAFT_233044 | calcium ion binding |
| c258721_g2 | vigilin-like | RNA binding |
| c265676_g3 | collagen alpha-3(VI) chain-like isoform X9 | protein binding |
| c264079_g1 | cilia- and flagella-associated protein 58-like | protein binding |
Figure 5Significantly enriched GO terms. Ref_per: Reference set, refers to the proportion of a GO classification in a total of identified proteins; Test_per: Test set; refers to the proportion of a GO classification in the differential identified proteins. This also applies to the following figures.
Figure 6Significantly enriched KEGG pathways.
Figure 7Statistics of most enriched KEGG pathways.
Top KEGG maps.
| Map ID | Map Name | Number of Sequence |
|---|---|---|
| ko03010 | Ribosome | 52 |
| ko01200 | Carbon metabolism | 42 |
| ko04142 | Lysosome | 28 |
| ko05016 | Huntington’s disease | 24 |
| ko04510 | Focal adhesion | 24 |
| ko01230 | Biosynthesis of amino acids | 24 |
| ko04151 | PI3K-Akt signaling pathway | 21 |
| ko04141 | protein processing in endoplasmic reticulum | 20 |
| ko05169 | Epstein-Barr virus infection | 19 |
| ko00010 | glycolysis/gluconeogenesis | 18 |
| ko04145 | phagosome | 18 |
| ko00230 | purine metabolism | 18 |
| ko03013 | RNA transport | 17 |
| ko05012 | Parkinson’s disease | 17 |
| ko00630 | glyoxylate and dicarboxylate metabolism | 17 |
| ko00020 | citrate cycle (TCA cycle) | 16 |
| ko05146 | amoebiasis | 16 |
| ko05200 | pathways in cancer | 16 |
| ko05205 | proteoglycans in cancer | 16 |
| ko00190 | oxidative phosphorylation | 16 |
| ko05203 | viral carcinogenesis | 15 |
Figure 8Predicted interactions of identified DEPs. Different line colours represent types of evidence for association. Four major clusters associated with neuron development (A), cilium assembly and motor protein (B), calcium and metal-binding (C), hydrolase (D). Proteins without interactions have been removed from the graph. Protein abbreviations and corresponding full name are shown: Transmembrane protease serine 3 (Tmprss3); 14-3-3 protein gamma (Ywhag); Mannan-binding lectin serine protease 1(Masp1); Hematopoietic prostaglandin D synthase (Hpgds); Kyphoscoliosis peptidase (Ky); Integrin beta-1 (Itgb1); Periostin precursor (Postn); Chymotrypsin-C (Ctrc); Intraflagellar transport protein 46 homolog (Ift46); Dipeptidyl peptidase 1 (Ctsc); Alpha-enolase (Eno1); Mast cell protease 1(rMCP-1); Tetratricopeptide repeat protein26 (Ttc26); SCO-spondin (Sspo); Calmodulin (ENSRNOG00000030871); Carboxypeptidase B precursor (Cpb1); Kinesin-like protein KLP6(RGD1559696); Cartilage oligomeric matrix protein precursor (Comp); Heat shock 70 kDa protein 1 A/1B (Hspa1). Nodes: Network nodes represent proteins; Node Size: small nodes and large nodes; Node Color: colored nodes: query proteins and first shell of interactors; white nodes: second shell of interactors; Edges: Edges represent protein-protein associations; Network Stats: average node degree: 0.642; avg. local clustering coefficient: 0.241; expected number of edges: 7; protein-protein interaction (PPI) enrichment p-value: 0.000792.
Figure 9Number of interactive network of protein co-expression.
Figure 10The mRNA expression of 17 DEPs. Different letters (for example (a–c)) indicate that variations were statistically different by Student’s t-test analysis (p < 0.05). In addition, if one of the two letters (aa, ab, bb) is the same, there is not statistically different.
Comparison of mRNA and protein expression levels for 17 genes.
| NO | Description | Expression pattern of mRNA | Expression pattern of proteins |
|---|---|---|---|
| 1 | chymotrypsin | ZRZ_VI > ZRZ_V > ZRZ_III | ZRZ_VI > ZRZ_V > ZRZ_III |
| 2 | amylase | ZRZ_V > ZRZ_VI > ZRZ_III | ZRZ_V > ZRZ_VI > ZRZ_III |
| 3 | cellulase | ZRZ_V > ZRZ_VI > ZRZ_III | ZRZ_V > ZRZ_VI > ZRZ_III |
| 4 | EF-hand calcium-binding domain-containing protein | *ZRZ_III > ZRZ_V > ZRZ_VI | ZRZ_V > ZRZ_VI = ZRZ_III |
| 5 | calcium-binding mitochondrial carrier protein SCaMC | aZRZ_III > ZRZ_V > ZRZ_VI | ZRZ_III > ZRZ_VI > ZRZ_V |
| 6 | calmodulin | bZRZ_V > ZRZ_III > ZRZ_VI | ZRZ_III > ZRZ_V = ZRZ_VI |
| 7 | C-type lectin | aZRZ_V > ZRZ_VI > ZRZ_III | ZRZ_III > ZRZ_V > ZRZ_VI |
| 8 | lysozyme | aZRZ_VI > ZRZ_III > ZRZ_V | ZRZ_V > ZRZ_VI > ZRZ_III |
| 9 | stress protein A | aZRZ_V > ZRZ_III > ZRZ_VI | ZRZ_VI > ZRZ_V > ZRZ_III |
| 10 | glutathione s-transferase | ZRZ_III > ZRZ_V > ZRZ_VI | ZRZ_III > ZRZ_V > ZRZ_VI |
| 11 | Hsp70 | aZRZ_III > ZRZ_VI > ZRZ_V | ZRZ_VI > ZRZ_III = ZRZ_V |
| 12 | cathepsin L | *ZRZ_VI > ZRZ_V > ZRZ_III | ZRZ_III > ZRZ_V > ZRZ_VI |
| 13 | 14-3-3 protein | *ZRZ_VI > ZRZ_V > ZRZ_III | ZRZ_V > ZRZ_VI = ZRZ_III |
| 14 | SCO-spondin | *ZRZ_V > ZRZ_VI > ZRZ_III | ZRZ_VI > ZRZ_V = ZRZ_III |
| 15 | kyphoscoliosis peptidase | ZRZ_V > ZRZ_III > ZRZ_VI | ZRZ_V > ZRZ_III > ZRZ_VI |
| 16 | radial spoke head 1 homolog | bZRZ_V > ZRZ_III > ZRZ_VI | ZRZ_III > ZRZ_V > ZRZ_VI |
| 17 | marginal zone B- and B1-cell-specific protein-like | ZRZ_VI > ZRZ_V > ZRZ_III | ZRZ_VI > ZRZ_V > ZRZ_III |
Note: The letter “a” showed P > 0.05 between three development stages; the letter “b” showed P > 0.05 between ZRZ_III and ZRZ_V; the symbol “*” showed different variations between proteins and mRNA expression pattern.